PTEN regulation by Akt-EGR1-ARF-PTEN axis

被引:109
作者
Yu, Jianxiu [1 ]
Zhang, Sharon S. [1 ,2 ]
Saito, Kan [1 ]
Williams, Scott [1 ]
Arimura, Yutaka [1 ]
Ma, Yuliang [1 ]
Ke, Yuehai [1 ]
Baron, Veronique [3 ]
Mercola, Dan [4 ]
Feng, Gen-Sheng [1 ]
Adamson, Eileen [1 ]
Mustelin, Tomas [1 ]
机构
[1] Burnham Inst Med Res, La Jolla, CA 92037 USA
[2] Univ Calif San Diego, Mol Pathol Grad Program, La Jolla, CA 92093 USA
[3] Sidney Kimmel Canc Ctr, San Diego, CA USA
[4] Univ Calif Irvine, Dept Med Sci, Irvine, CA USA
关键词
EGR1; p14ARF/p19ARF; PTEN; sumoylation; tumour suppression; FUSION-DIRECTED SUMOYLATION; ARF TUMOR-SUPPRESSOR; TRANSCRIPTION FACTOR; EGR-1; TRANSCRIPTION; HT1080; CELLS; P53; PROTEIN; GROWTH; GENE; PROMOTES;
D O I
10.1038/emboj.2008.238
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The PTEN tumour suppressor gene is induced by the early growth response 1 (EGR1) transcription factor, which also transactivates p53, p73, and p300/CBP as well as other proapoptotic and anti-cancer genes. Here, we describe a novel Akt-EGR1-alternate reading frame (ARF)-PTEN axis, in which PTEN activation in vivo requires p14ARF-mediated sumoylation of EGR1. This modification is dependent on the phosphorylation of EGR1 at S350 and T309 by Akt, which promotes interaction of EGR1 with ARF at K272 in its repressor domain by the ARF/Ubc9/SUMO system. EGR1 sumoylation is decreased by ARF reduction, and no EGR1 sumoylation is detected in ARF(-/-) mice, which also exhibit reduced amounts of PTEN. Our model predicts that perturbation of any of the clinically important tumour suppressors, PTEN, EGR1, and ARF, will cause some degree of dysfunction of the others. These results also explain the known negative feedback regulation by PTEN on its own synthesis through PI3 kinase inhibition.
引用
收藏
页码:21 / 33
页数:13
相关论文
共 42 条
[1]   Negative feedback regulation of the tumor suppressor PTEN by phosphoinositide-induced serine phosphorylation [J].
Birle, D ;
Bottini, N ;
Williams, S ;
Huynh, H ;
deBelle, I ;
Adamson, E ;
Mustelin, T .
JOURNAL OF IMMUNOLOGY, 2002, 169 (01) :286-291
[2]   The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans [J].
Carrasco, Daniel R. ;
Fenton, Tim ;
Sukhdeo, Kumar ;
Protopopova, Marina ;
Enos, Miriam ;
You, Mingjian J. ;
Divicio, Dolores ;
Nogueira, Cristina ;
Stommel, Jayne ;
Pinkus, Geraldine S. ;
Fletcher, Christopher ;
Hornick, Jason L. ;
Cavenee, Webster K. ;
Furnari, Frank B. ;
DePinho, Ronald A. .
CANCER CELL, 2006, 9 (05) :379-390
[3]   MDM2-ARF complex regulates p53 sumoylation [J].
Chen, LH ;
Chen, JD .
ONCOGENE, 2003, 22 (34) :5348-5357
[4]  
Davies MA, 1999, CANCER RES, V59, P2551
[5]   P53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis [J].
de Belle, I ;
Huang, RP ;
Fan, Y ;
Liu, CT ;
Mercola, D ;
Adamson, ED .
ONCOGENE, 1999, 18 (24) :3633-3642
[6]  
den Besten W, 2006, ISR MED ASSOC J, V8, P249
[7]   Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14ARF tumor suppressor [J].
Dimri, GP ;
Itahana, K ;
Acosta, M ;
Campisi, J .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (01) :273-285
[8]   Polymerase chain reaction-based diagnosis of Del(5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval [J].
Horrigan, SK ;
Westbrook, CA ;
Kim, AH ;
Banerjee, M ;
Stock, W ;
Larson, RA .
BLOOD, 1996, 88 (07) :2665-2670
[9]  
Huang RP, 1998, INT J CANCER, V77, P880, DOI 10.1002/(SICI)1097-0215(19980911)77:6<880::AID-IJC14>3.0.CO
[10]  
2-5